vimarsana.com
Home
Live Updates
Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies : vimarsana.com
Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies
EQS-News: Evotec SE
/ Key word: Miscellaneous
Evotec and Crohn´s & Colitis Foundation enter agreement to advance drug discovery for novel IBD therapies
10.01.2024 /...
Related Keywords
United States
,
Germany
,
New York
,
Hamburg
,
Americans
,
Jennifer Swantek
,
Matthias Evers
,
Hinnerk Rohwedder
,
Gabriele Hansen
,
Hurtado Lorenzo
,
Volker Braun
,
Distribution Services
,
Crohn Colitis Foundation
,
Colitis Foundation
,
Nasdaq
,
Head Of Global Corporate Communications
,
Crohn Colitis Foundation The
,
Global Corporate Communications
,
Translational Research
,
Evotec Se Frankfurt Stock Exchange
,
Linkedin
,
Frankfurt Stock Exchange
,
Chief Business Officer
,
Senior Vice President
,
Global Investor Relations
,
Corporate News
,
Regulatory Announcements
,
Markets
,
vimarsana.com © 2020. All Rights Reserved.